New dialysis fluid may protect heart health in kidney patients
NCT ID NCT07163936
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 27 times
Summary
This study tests if a citrate-based dialysis fluid with added magnesium can slow or prevent hardening of blood vessels (vascular calcification) in adults on long-term hemodialysis. Researchers will compare this new fluid to standard acetate-based fluid in 80 patients over 12 months, using blood tests and monitoring heart problems. The goal is to find a safer way to manage dialysis and reduce cardiovascular risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMODIALYSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.